checkAd
    Startseite > Aktien > Lexicon Pharmaceuticals > Nachrichten
    Lexicon Pharmaceuticals Aktie
    1,6200
     
    USD
    +5,19 %
    +0,0800 USD
    Letzter Kurs 22:03:27 Nasdaq
    1,6400
     
    USD
    110.300 STK
    Geldkurs 22:02:00
    1,6500
     
    USD
    26.400 STK
    Briefkurs 22:02:00
    ISIN: US5288723027 · WKN: A14SSK · SYM: LXRX · USA

    Neueste Nachrichten

    Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
    29.04.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024
    29.04.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals to Host 2024 Investor Day
    18.04.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    03.04.24 · globenewswire · Lexicon Pharmaceuticals
    Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
    25.03.24 · globenewswire · Lexicon Pharmaceuticals
    New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
    12.03.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update
    11.03.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
    11.03.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
    11.03.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference
    08.01.24 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference
    21.12.23 · globenewswire · Lexicon Pharmaceuticals
    Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
    30.11.23 · globenewswire · Lexicon Pharmaceuticals